During a virtual panel, leaders from across the industry shared their advice on how health plans can do a better job of achieving their goals for chronic management. For example, one executive said health plans should utilize remote monitoring tools for centralized observation and be wary of using the wrong metrics.
Medical algorithms will continue to preserve the racial bias that has been historically baked into the U.S. healthcare system unless the medical field stops operationalizing race in its machine learning models, according to panelists at a recent panel hosted by the Philadelphia Alliance for Capital and Technologies. They argued algorithms should use social determinants of health as a predictor of health outcomes instead of race.
Hear executives from Quantum Health, Surescripts, EY, Clinical Architecture and Personify Health share their views on digital transformation in healthcare.
The IBC Foundation Institute for Health Equity's initial focus areas will include digital health, cultural competence in medicine and maternal health. The money committed for the creation of the Institute will be spent over a five-year period.
Among the technologies represented by the group are medtech sensors tracking blood pressure, ostomy patient complications, tremor progression in Parkinson's disease patients, balance, cerebrospinal fluid levels, and more.
The panel, What It Takes To Build A Successful, Regional BioInnovation Hub (sponsored by Independence Blue Cross) focuses on Philadelphia — one of many cities seeking to support the continued growth of cell and gene therapy and connected health industries.
Here's a preview of some of the panel discussions at INVEST Precision Medicine, including diagnostics, investment trends, and building a bioinnovation hub.
As technology advances, AI-powered tools will increasingly reduce the administrative burdens on healthcare providers.
Companies ranging from American Well to Comcast to Independence Blue Cross are looking to the television sets in people's home as a healthcare delivery method.
Health tech applications in the realm of cancer treatment will be a major theme of the CONVERGE conference in Philadelphia June 19 in Philadelphia, from improving the patient experience to AI. Register now!
A roundup of some of the biggest trends and events in pharmaceuticals, biotechnology and diagnostics in 2018, including regulatory approvals, international trends, national policy and more.
In January 2016, Independence Blue Cross and NantHealth announced the nation's first coverage for a whole genome sequencing and proteome molecular diagnostic platform, but it's mostly slipped under the radar since then. What's going on?
The progress in artificial intelligence (AI) is reshaping patient care, across various dimensions, from facilitating faster discharge to curating treatment plans and suggesting lifestyle changes.
Not only have a significant number of entrepreneurs had successful exits, but they are going on to start their next healthcare ventures in the Philadelphia area.
The unique initiative pairs a health insurer with a cable corporation with the goal of improving access to healthcare through health education content and telemedicine.
Simply put, working together is better than working alone. At MedCity CONVERGE, three panelists discussed an organization based on the idea of collaboration: the Philadelphia Coalition for a Cure, which is seeking to put an end to brain cancer.
Eight healthcare startups, half of them led by women, offered myriad approaches to solving specific healthcare challenges from more efficient nurse training to remote monitoring for home infusion and diabetic neuropathy.
“There’s not enough money in the average person’s pocket to take care of the increases in premiums companies would have to charge,” said Dr. Richard Snyder, senior vice president and chief medical officer for Independence Blue Cross.